Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Pandemic Encourages Innovative Thinking and New Partnerships in the Healthcare Industry

John Elliott, VP, Sales at Carevive spoke with Host Daniel J. Litwin on his observations about the industry at the HLTH 2021 Tradeshow in Boston, Mass. Elliott noted many positive trends during the show and will benefit all in the industry, but most importantly the patients. The biggest takeaways from the show in Elliott’s opinion…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Carevive on MarketScale.

Share

John Elliott, VP, Sales at Carevive spoke with Host Daniel J. Litwin on his observations about the industry at the HLTH 2021 Tradeshow in Boston, Mass.

Elliott noted many positive trends during the show and will benefit all in the industry, but most importantly the patients.

The biggest takeaways from the show in Elliott’s opinion are:

  • The investor community in attendance hoping to provide innovation resources
  • An eagerness for a collaborative approach
  • Acting on data-centric information
  • “The time is now” essence

Overall, attendees and exhibitors came equipped with a problem-solving mindset. Elliott believes the industry is on the precipice of something big with major tech vendors in attendance and companies thinking innovatively to solve problems.

“You’re pulling in skillsets or talent that traditionally hasn’t been invested in or focused on healthcare; I think there has been a shift. A health system having an innovation team or even an own strategic investment team on where they can work with third party partners, and they’re allocating their own investment or capital funds to fill gaps.”

To put it short, it’s disruptive to the industry in the best way and is one example of how the pandemic is having a positive impact on the healthcare industry.

However, the pandemic has posed significant problems for many in healthcare, and oncology is no exception. Traditional chemo infusion was impacted by COVID-19, making it unsafe for the immune-compromised to receive treatment. Luckily, they were able to transition to an oral regimen for a safer patient experience. However, what was the downstream impact on those patients? Luckily, Carevive had the technology to help care teams better support their patients.

Carevive serves as a cancer management platform for improving patient experience throughout the cancer journey. To find more information, visit Carevive.com or contact john.elliott@carevive.com.

Carevive

Part of this channel

Carevive

Remote oncology monitoring that connects clinicians and cancer patients between visits.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512